(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are Everbridge, Glatfelter, and DAQO New Energy.

Rank Financial Asset Price Change Updated (EST)
1 Everbridge (EVBG) 41.91 17.17% 2022-08-26 14:54:53
2 Glatfelter (GLT) 5.31 8.15% 2022-08-26 06:09:52
3 DAQO New Energy (DQ) 71.73 7.77% 2022-08-26 14:59:23
4 Zai Lab (ZLAB) 46.88 5.14% 2022-08-26 14:55:51
5 Kosmos Energy (KOS) 7.24 5% 2022-08-26 14:47:29
6 Globalstar (GSAT) 1.98 4.5% 2022-08-26 14:54:42
7 Gol Linhas Aereas Inteligentes S.A. Sponsored ADR representing (GOL) 4.67 4.47% 2022-08-26 07:09:06
8 Green Dot Corporation (GDOT) 21.52 4.06% 2022-08-26 03:46:16
9 Foot Locker (FL) 37.96 4.03% 2022-08-25 23:47:15
10 FNF Group of Fidelity National Financial (FNF) 40.83 3.66% 2022-08-26 01:10:05

The three most active and biggest losers today are Dell, Pacific Biosciences of California, and Marathon.

Rank Financial Asset Price Change Updated (EST)
1 Dell (DELL) 41.40 -13.56% 2022-08-26 14:54:39
2 Pacific Biosciences of California (PACB) 5.97 -13.55% 2022-08-26 14:58:54
3 Marathon (MARA) 11.44 -11.14% 2022-08-26 14:57:55
4 Rock (RKT) 8.42 -10.94% 2022-08-26 14:50:32
5 Restoration Hardware Holdings (RH) 265.18 -10% 2022-08-26 14:50:21
6 10x Genomics (TXG) 34.90 -9.76% 2022-08-26 14:49:46
7 Bionano Genomics (BNGO) 2.59 -9.62% 2022-08-26 14:46:39
8 Arcturus Therapeutics (ARCT) 15.01 -9.47% 2022-08-26 14:46:21
9 3M Company (MMM) 129.57 -9.24% 2022-08-26 14:55:59
10 NVIDIA (NVDA) 162.81 -9.11% 2022-08-26 14:58:44

Most Active Winners today

1. Everbridge (EVBG) – 17.17%

Everbridge, Inc. is a software company that provides software solutions to automate and speed up organizations’ response to major events, both domestically and internationally. Critical Event Management is a platform that offers software-as-a-service. It includes various software programs to help organizations manage critical events. The company serves small and medium-sized businesses as well as educational and government agencies. It is available to all levels of technology, finance, health, life sciences, manufacturing and media, education and retail. 3n Global, Inc. was the company’s previous name. In April 2009, Everbridge, Inc. became Everbridge, Inc. It was established in 2002. The headquarters are located in Burlington in Massachusetts.

NASDAQ ended the session with Everbridge rising 17.17% to $41.91 on Friday while NASDAQ slid 3.94% to $12,141.71.

Volume

Today’s last reported volume for Everbridge is 2686960 which is 250.9% above its average volume of 765727.

Everbridge’s last close was $35.77, 78.63% under its 52-week high of $167.40.

Everbridge’s Sales

Everbridge’s sales growth is 14.5% for the current quarter and 13% for the next. The company’s growth estimates for the present quarter and the next is 220% and 440%, respectively.

Everbridge’s Revenue

Year-on-year quarterly revenue growth grew by 22.1%, now sitting on 386.6M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Everbridge’s stock is considered to be oversold (<=20).

Everbridge’s Stock Yearly Top and Bottom Value

Everbridge’s stock is valued at $41.91 at 17:32 EST, way below its 52-week high of $167.40 and way above its 52-week low of $24.10.

Everbridge’s Moving Average

Everbridge’s worth is way above its 50-day moving average of $30.39 and way under its 200-day moving average of $53.90.

More news about Everbridge.

2. Glatfelter (GLT) – 8.15%

Glatfelter Corporation and its subsidiaries manufacture and sell engineered materials around the world. The company operated in two segments: Composite Fibers, and Airlaid Materials. Composite Fibers is the company’s food and beverage filter paper. It also offers wall covering bases for wallpaper producers. Special paper products are available for electrical energy storage, homecare and hygiene as well as for other fiber-based engineered applications. The Advanced Airlaid Materials segment provides absorbent, cellulose-based nonwoven products that can be used in the manufacture of consumer products such as feminine hygiene and specialty wipes, table top, adult genital, home care, and many other products. It markets products both directly and through agents, brokers, and other intermediaries. The former name of the company was P. H. Glatfelter Company. Glatfelter Corporation was established in 1864. It is located in Charlotte, North Carolina.

NYSE ended the session with Glatfelter rising 8.15% to $5.31 on Friday, following the last session’s upward trend. NYSE dropped 0.02% to $15,338.15, after two sequential sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Glatfelter is 489413 which is 29.7% above its average volume of 377329.

Glatfelter’s last close was $5.31, 71.66% under its 52-week high of $18.74.

The company’s growth estimates for the present quarter and the next is a negative 227.8% and a negative 47.6%, respectively.

Glatfelter’s Revenue

Year-on-year quarterly revenue growth grew by 69.1%, now sitting on 1.24B for the twelve trailing months.

Glatfelter’s Stock Yearly Top and Bottom Value

Glatfelter’s stock is valued at $5.31 at 17:32 EST, way under its 52-week high of $18.74 and above its 52-week low of $4.88.

Glatfelter’s Moving Average

Glatfelter’s value is way below its 50-day moving average of $6.25 and way below its 200-day moving average of $11.95.

More news about Glatfelter.

3. DAQO New Energy (DQ) – 7.77%

Daqo New Energy Corp. and its subsidiaries manufactures and distributes photovoltaic products manufactured from polysilicon in China. These products can be used to make solar power modules, ingots and wafers. Mega Stand International Limited was the company’s previous name. In August 2009, Daqo New Energy Corp. took over that title. Daqo New Energy Corp. is located in Shanghai in the People’s Republic of China.

NYSE ended the session with DAQO New Energy rising 7.77% to $71.73 on Friday, following the last session’s upward trend. NYSE dropped 0.02% to $15,338.15, after two successive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for DAQO New Energy is 4879450 which is 172.72% above its average volume of 1789120.

DAQO New Energy’s last close was $66.56, 17.93% under its 52-week high of $81.10.

DAQO New Energy’s Sales

DAQO New Energy’s sales growth is 113.2% for the current quarter and 107.4% for the next. The company’s growth estimates for the ongoing quarter and the next is 50.3% and 125.8%, respectively.

DAQO New Energy’s Revenue

Year-on-year quarterly revenue growth grew by 399.9%, now sitting on 2.7B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

DAQO New Energy’s stock is considered to be overbought (>=80).

DAQO New Energy’s Stock Yearly Top and Bottom Value

DAQO New Energy’s stock is valued at $71.73 at 17:32 EST, way below its 52-week high of $81.10 and way higher than its 52-week low of $32.20.

DAQO New Energy’s Moving Average

DAQO New Energy’s worth is higher than its 50-day moving average of $65.67 and way higher than its 200-day moving average of $50.98.

More news about DAQO New Energy.

4. Zai Lab (ZLAB) – 5.14%

Zai Lab Limited is a company that develops and markets therapies for oncology and autoimmune disorders. It also has a focus in neuroscience. Zejula is a once daily small-molecule, poly polymerase 1/2 inhibitor. Optune delivers treatment fields to tumors. NUZYRA treats skin structures and acute bacterial infections. Qinlock can treat gastrointestinal tumors. Odronextamab is also developed to treat diffuse large B cell lymphoma and other types of B-celllymphoma; Repotrectinib (a tyrosinekinase inhibitor) to target ROS1 or TRK A/B/C patients who have been treated with TKI; Margetuximab to treat breast and stomach cancers; Adagrasib to deal with KRAS G12C-mutated NSCLC and pancreatic cancer; and Bemarituzumab treatment for gastric junction and gastroesophageal and stomach cancer. In addition, the company develops CLN-081 for the treatment of patients with EGFR exon 20 insertion NSCLC; Elzovantinib, an orally bioavailable multi-targeted kinase inhibitor; Tebotelimab, a tetravalent IgG4 monoclonal antibody; Retifanlimab that inhibits interactions between PD-1 and its ligands; ZL-2309, an orally active, selective, and ATP-competitive cell division cycle 7 (CDC7) kinase inhibitor; ZL-1201, a humanized IgG4 monoclonal antibody; Efgartigimod to reduce disease-causing immunoglobulin G antibodies; ZL-1102, a human nanobody targeting interleukin- 17A; KarXT for the treatment of psychiatric and neurological conditions; ZL-2313, an investigational inhibitor of triple-mutant EGFR harboring; ZL-2314, an investigational inhibitor of double-mutant EGFR harboring; and Sulbactam/durlobactam for the treatment of serious infections caused by Acinetobacter. Zai Lab Limited, a Shanghai-based company was established in 2013.

NASDAQ ended the session with Zai Lab rising 5.14% to $46.88 on Friday, after three successive sessions in a row of gains. NASDAQ dropped 3.94% to $12,141.71, after two consecutive sessions in a row of gains, on what was a very bearish trend exchanging session today.

Volume

Today’s last reported volume for Zai Lab is 856527 which is 45.74% above its average volume of 587670.

Zai Lab’s last close was $44.59, 70.82% under its 52-week high of $152.82.

Zai Lab’s Sales

Zai Lab’s sales growth is 56.6% for the ongoing quarter and 29.6% for the next.

Zai Lab’s Revenue

Year-on-year quarterly revenue growth grew by 132.4%, now sitting on 170.93M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Zai Lab’s stock is considered to be oversold (<=20).

Zai Lab’s Stock Yearly Top and Bottom Value

Zai Lab’s stock is valued at $46.88 at 17:32 EST, way under its 52-week high of $152.82 and way higher than its 52-week low of $22.51.

Zai Lab’s Moving Average

Zai Lab’s worth is way higher than its 50-day moving average of $38.17 and below its 200-day moving average of $48.58.

More news about Zai Lab.

5. Kosmos Energy (KOS) – 5%

Kosmos Energy Ltd. is a independent deep-water oil and gas exploration company that focuses on the Atlantic Margins. Its main assets are production off Ghana and Equatorial Guinea and the U.S. Gulf of Mexico. There is also a gas development project offshore Mauritania, Senegal, and offshore Mauritania. The company also has a well-developed basin exploration program. It was established in 2003 in Dallas, Texas.

NYSE ended the session with Kosmos Energy rising 5% to $7.24 on Friday while NYSE slid 0.02% to $15,338.15.

Volume

Today’s last reported volume for Kosmos Energy is 5145700 which is 33.95% below its average volume of 7791370.

Kosmos Energy’s last close was $6.90, 18.73% below its 52-week high of $8.49.

Kosmos Energy’s Revenue

Year-on-year quarterly revenue growth grew by 273.3%, now sitting on 1.81B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Kosmos Energy’s stock is considered to be oversold (<=20).

Kosmos Energy’s Stock Yearly Top and Bottom Value

Kosmos Energy’s stock is valued at $7.24 at 17:33 EST, way under its 52-week high of $8.49 and way higher than its 52-week low of $1.80.

Kosmos Energy’s Moving Average

Kosmos Energy’s value is way above its 50-day moving average of $6.37 and way higher than its 200-day moving average of $5.52.

More news about Kosmos Energy.

6. Globalstar (GSAT) – 4.5%

Globalstar, Inc. offers mobile satellite services around the world. Globalstar, Inc. offers two-way duplex voice and information products. These include mobile voice and satellite communication services for business continuity and remote use, safety, emergency preparation and response and other applications. It also provides fixed voice and satellite communications services at residential, industrial and commercial sites as well as equipment and rural services. The company also offers SPOT consumer products such as SPOT GPS Messenger for personal tracking and emergency location; and SPOT Trace which is an anti-theft device and asset tracker. The company also offers Internet of Things commercial one-way transmission products that can track rail cars and cargo containers, as well monitor utilities meters and oil and natural gas assets. It also sells wholesale minutes directly to IGOs. Additionally, the company offers engineering services such as software and hardware designs for specific applications, and installation of antennas and gateways. It distributes products direct, through dealers, resellers and independent agents as well as via e-commerce websites, sales staff, a sales force, and an e-commerce website. It had approximately 745k subscribers as of December 31, 2020. It serves the recreation, personal, government and public safety as well as disaster relief and oil and gas. Globalstar, Inc. and XCOM Labs have formed a strategic alliance to commercialize XCOM’s capacity-multiplying technology together with Globalstar’s Band n53 in order for 5G deployments within the United States of America, as well as other countries that Globalstar holds terrestrial rights. Company was established in 1993 in Covington Louisiana.

NYSE ended the session with Globalstar rising 4.5% to $1.98 on Friday, after two consecutive sessions in a row of losses. NYSE fell 0.02% to $15,338.15, after two sequential sessions in a row of gains, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Globalstar is 17566200 which is 293.86% above its average volume of 4459910.

Globalstar’s Sales

Globalstar’s sales growth is a negative 13.3% for the present quarter and a decline by 13.7% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Globalstar’s stock is considered to be oversold (<=20).

More news about Globalstar.

7. Gol Linhas Aereas Inteligentes S.A. Sponsored ADR representing (GOL) – 4.47%

GOL Linhas (c)reas Inteligentes S.A. offers air passenger transport services throughout Brazil, South America and the Caribbean. It operates via segments of Flight Transportation and Smiles Loyalty Programme. The company also provides logistics and cargo transport services. The company also offers Smiles loyalty programs, with 16.9 million members. Clients can accumulate miles and redeem them. It operated a fleet consisting of 131 Boeing planes with approximately 750 daily flights to around 100 destinations. GOL Linhas AA (c)reas Inteligentes S.A was established in 2000. It is based in SAPSo Paulo in Brazil.

NYSE ended the session with Gol Linhas Aereas Inteligentes S.A. Sponsored ADR representing jumping 4.47% to $4.67 on Friday while NYSE fell 0.02% to $15,338.15.

Volume

Today’s last reported volume for Gol Linhas Aereas Inteligentes S.A. Sponsored ADR representing is 2115230 which is 0.02% below its average volume of 2115800.

Gol Linhas Aereas Inteligentes S.A. Sponsored ADR representing’s last close was $4.67, 44.27% under its 52-week high of $8.38.

Gol Linhas Aereas Inteligentes S.A. Sponsored ADR representing’s Sales

Gol Linhas Aereas Inteligentes S.A. Sponsored ADR representing’s sales growth is 129.9% for the present quarter and 88.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 93% and 109.8%, respectively.

Gol Linhas Aereas Inteligentes S.A. Sponsored ADR representing’s Revenue

Year-on-year quarterly revenue growth grew by 215.3%, now sitting on 11.3B for the twelve trailing months.

Gol Linhas Aereas Inteligentes S.A. Sponsored ADR representing’s Stock Yearly Top and Bottom Value

Gol Linhas Aereas Inteligentes S.A. Sponsored ADR representing’s stock is valued at $4.67 at 17:33 EST, way under its 52-week high of $8.38 and way above its 52-week low of $2.74.

Gol Linhas Aereas Inteligentes S.A. Sponsored ADR representing’s Moving Average

Gol Linhas Aereas Inteligentes S.A. Sponsored ADR representing’s value is way higher than its 50-day moving average of $3.62 and way under its 200-day moving average of $5.56.

More news about Gol Linhas Aereas Inteligentes S.A. Sponsored ADR representing.

8. Green Dot Corporation (GDOT) – 4.06%

Green Dot Corporation is a bank holding and financial technology company in the United States. The company operates two divisions: Account Services and Processing and Settlement Services. It offers deposit accounts programs under network-branded reloadable debit cards that are branded with GPR card brand consumer names, small-business checking accounts, gift cards network-branded, secured credit cards and consumer banking services. The company also offers swipe reload to credit cash on an enabled card through a participating Green Dot Network retailer. MoneyPak allows consumers to add funds and transfer money to their accounts. Simply Paid provides disbursement services. The company also offers debit and prepaid cards as well as payroll and debit cards. It can issue, settle, or manage capital as well as services such as wage disbursements and refund processing, aswell as issuance, settlement,, and capital management. It also offers mobile banking, loan disbursement account, mobile P2P and money transfer. It markets its products as Green Dot and GoBank, MoneyPaks, AccountNow, RushCard, RapidPay. Green Dot Corporation sells and markets its products through retail shops, direct-to consumer Websites, corporate distribution partners, individual tax preparers and tax preparation firms, apps and through the A’Banking As a Service’ portal. The previous name of the company was Next Estate Communications, Inc., but it changed its name in October 2005 to Green Dot Corporation. Green Dot Corporation was founded in 1999. It is located in Pasadena (California).

NYSE ended the session with Green Dot Corporation jumping 4.06% to $21.52 on Friday, following the last session’s upward trend. NYSE slid 0.02% to $15,338.15, after two successive sessions in a row of gains, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Green Dot Corporation is 732528 which is 51.65% above its average volume of 483022.

Green Dot Corporation’s last close was $21.52, 60.8% under its 52-week high of $54.90.

Green Dot Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 1.8%, now sitting on 1.44B for the twelve trailing months.

Green Dot Corporation’s Stock Yearly Top and Bottom Value

Green Dot Corporation’s stock is valued at $21.52 at 17:33 EST, way under its 52-week high of $54.90 and higher than its 52-week low of $20.65.

Green Dot Corporation’s Moving Average

Green Dot Corporation’s value is way below its 50-day moving average of $24.99 and way below its 200-day moving average of $29.68.

More news about Green Dot Corporation.

9. Foot Locker (FL) – 4.03%

Foot Locker, Inc., via its subsidiaries, is an apparel and athletic footwear retailer. It sells footwear, apparel and accessories under the Foot Locker and Lady Foot Locker brands. Champs Sports and Eastbay are also represented by this company. The company also offers licensed merchandise to high school athletes and others. In addition, the company operates sites for eastbay.com, final-score.com, and eastbayteamsales.com, as well as footlocker.com, ladyfootlocker.com, kidsfootlocker.com, champssports.com, footaction.com, footlocker.ca, footlocker.eu, footlocker.com.au, runnerspoint.com, sidestep-shoes.com, footlocker.hk, footlocker.sg, and footlocker.my. It had 3,129 stores across 27 countries, including Australia, Asia, Australia and New Zealand, as of August 16, 2020. Foot Locker, Inc., was established in New York, New York, in 1879.

NYSE ended the session with Foot Locker rising 4.03% to $37.96 on Friday, following the last session’s upward trend. NYSE slid 0.02% to $15,338.15, after two successive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Foot Locker is 2428830 which is 17.02% below its average volume of 2927010.

Foot Locker’s last close was $37.96, 34.91% under its 52-week high of $58.32.

The company’s growth estimates for the current quarter and the next is a negative 61.1% and a negative 27.5%, respectively.

Foot Locker’s Revenue

Year-on-year quarterly revenue growth declined by 9.2%, now sitting on 8.77B for the twelve trailing months.

Foot Locker’s Stock Yearly Top and Bottom Value

Foot Locker’s stock is valued at $37.96 at 17:33 EST, way below its 52-week high of $58.32 and way higher than its 52-week low of $23.85.

Foot Locker’s Moving Average

Foot Locker’s value is way above its 50-day moving average of $28.86 and above its 200-day moving average of $35.46.

More news about Foot Locker.

10. FNF Group of Fidelity National Financial (FNF) – 3.66%

Fidelity National Financial, Inc. and its affiliates offer a variety of insurance products throughout the United States. It operates in two segments: Corporate, Title and Other. The company offers title insurance and escrow as well as other title-related services such trust activities, trustee guarantees, recordings, conveyances and insurance home warranty. It also offers technology and transaction services for the mortgage and real estate industries. It also engages in real estate brokerage. It was established in 1847, and its headquarters are in Jacksonville, Florida.

NYSE ended the session with FNF Group of Fidelity National Financial rising 3.66% to $40.83 on Friday while NYSE slid 0.02% to $15,338.15.

Volume

Today’s last reported volume for FNF Group of Fidelity National Financial is 1474050 which is 0.33% above its average volume of 1469090.

FNF Group of Fidelity National Financial’s last close was $40.83, 27.66% under its 52-week high of $56.44.

The company’s growth estimates for the current quarter and the next is a negative 26.9% and a negative 31%, respectively.

FNF Group of Fidelity National Financial’s Revenue

Year-on-year quarterly revenue growth declined by 31.6%, now sitting on 14.49B for the twelve trailing months.

FNF Group of Fidelity National Financial’s Stock Yearly Top and Bottom Value

FNF Group of Fidelity National Financial’s stock is valued at $40.83 at 17:34 EST, way below its 52-week high of $56.44 and way higher than its 52-week low of $34.59.

FNF Group of Fidelity National Financial’s Moving Average

FNF Group of Fidelity National Financial’s worth is higher than its 50-day moving average of $38.24 and under its 200-day moving average of $44.99.

More news about FNF Group of Fidelity National Financial.

Most Active Losers Today

1. Dell (DELL) – -13.56%

Dell Technologies Inc. develops, produces, markets, sales, supports, and maintains information technology solutions (IT) products and services around the world. It operates in three main segments, the Infrastructure Solutions Group (ISG), Client Solutions Groups (CSG), as well as VMware. ISG provides storage solutions, including traditional and next-generation, as well rack, blade tower and hyperscale servers. The segment offers networking products that enable customers to modernize and transform their infrastructures, enrich and mobilize end-user experience, accelerate business processes, as well as attached software and peripherals. It also provides support, deployment, configuration and extended warranties services. CSG provides workstations and notebooks as well as displays, projectors and attached software. It also offers support, deployment and configuration services. Customers can get support from the VMware segment in areas such as hybrid and multicloud, modern apps, networking, security and digital workspaces. This allows customers to manage IT resources across both private and complex multicloud and multi-device environments. Dell Technologies Inc. also provides information security; and cloud software and infrastructure-as-a-service solutions that enable customers to migrate, run, and manage mission-critical applications in cloud-based IT environments. It was previously known as Denali Holding Inc., but it changed its name in August 2016 to Dell Technologies Inc. Dell Technologies Inc. was established in 1984. It is located in Round Rock Texas.

NYSE ended the session with Dell falling 13.56% to $41.40 on Friday, after two consecutive sessions in a row of gains. NYSE slid 0.02% to $15,338.15, after two consecutive sessions in a row of gains, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Dell is 11442400 which is 234.88% above its average volume of 3416810.

Dell’s last close was $47.90, 22.16% under its 52-week high of $61.54.

Dell’s Sales

Dell’s sales growth is 2.5% for the current quarter and a decline by 1.4% for the next. The company’s growth estimates for the present quarter and the next is a negative 34.3% and a negative 32.1%, respectively.

Dell’s Revenue

Year-on-year quarterly revenue growth grew by 7.2%, now sitting on 101.2B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Dell’s stock is considered to be overbought (>=80).

Dell’s Stock Yearly Top and Bottom Value

Dell’s stock is valued at $41.40 at 17:34 EST, way below its 52-week high of $61.54 and higher than its 52-week low of $38.33.

Dell’s Moving Average

Dell’s value is way under its 50-day moving average of $47.05 and way under its 200-day moving average of $52.97.

More news about Dell.

2. Pacific Biosciences of California (PACB) – -13.55%

Pacific Biosciences of California, Inc. develops, manufactures, and markets sequencing systems for complex genetic problems. PacBio’s Systems are used to monitor and analyze biochemical sequence reactions. The company also offers consumables such as single molecule real time (SMRT), cells and various reagent kit designs for specific workflows. For example, the template preparation kit is used to convert DNA into SMRTbell double stranded library formats. This includes molecular biology reagents such as ligase and buffers. The company also sells binding kits such as the modified DNA polymerase, which is used to bind SMRTbell library to the polymerase to prepare for sequencing. Sequencing kits include reagents that are required to perform on-instrument real-time sequencing including the phospholinked nuclear nucleotides. It serves commercial labs; research centers; genome centres; hospitals, public health laboratories, clinical research institutes, contract researchers organizations, academic institutions, pharmaceutical companies, and agricultural businesses. The company markets its products via a direct sales force throughout North America and Europe as well as distribution partners across Asia, Europe and the Middle East. Invitae Corporation has signed a partnership agreement for Pacific Biosciences of California, Inc.’s development and commercialization. The company used to be known as Nanofluidics, Inc. but changed its name in 2005 to Pacific Biosciences of California, Inc. Pacific Biosciences of California, Inc., was founded in 2000. It is located in Menlo Park, California.

NASDAQ ended the session with Pacific Biosciences of California sliding 13.55% to $5.97 on Friday, after three successive sessions in a row of gains. NASDAQ fell 3.94% to $12,141.71, after two consecutive sessions in a row of gains, on what was a very bearish trend exchanging session today.

Volume

Today’s last reported volume for Pacific Biosciences of California is 7131820 which is 14.49% below its average volume of 8340780.

Pacific Biosciences of California’s last close was $6.90, 78.8% under its 52-week high of $32.55.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 1.5% for the present quarter and 4.4% for the next.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 15.9%, now sitting on 139.55M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pacific Biosciences of California’s stock is considered to be oversold (<=20).

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $5.97 at 17:35 EST, way under its 52-week high of $32.55 and way above its 52-week low of $3.85.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is way above its 50-day moving average of $5.30 and way under its 200-day moving average of $11.24.

More news about Pacific Biosciences of California.

3. Marathon (MARA) – -11.14%

Marathon Digital Holdings, Inc. is a company that produces digital assets. It mines cryptocurrency with an emphasis on the Blockchain ecosystem and the creation of digital assets in the United States. It had 8,115 bitcoins as of December 31, 2021. This includes the 4,794 bitcoins in its investment fund. Marathon Patent Group, Inc. was the company’s former name. In February 2021, Marathon Digital Holdings, Inc. took over its business. Marathon Digital Holdings, Inc. is an American company that was founded in 2010. Its headquarters are located in Las Vegas, Nevada.

NASDAQ ended the session with Marathon dropping 11.14% to $11.44 on Friday while NASDAQ dropped 3.94% to $12,141.71.

Volume

Today’s last reported volume for Marathon is 19920500 which is 3.83% above its average volume of 19185600.

Marathon’s last close was $12.88, 84.57% below its 52-week high of $83.45.

Marathon’s Sales

Marathon’s sales growth is 42% for the current quarter and 39.7% for the next. The company’s growth estimates for the present quarter and the next is 79.8% and 104.5%, respectively.

Marathon’s Revenue

Year-on-year quarterly revenue growth grew by 465%, now sitting on 193.03M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Marathon’s stock is considered to be overbought (>=80).

Marathon’s Stock Yearly Top and Bottom Value

Marathon’s stock is valued at $11.44 at 17:35 EST, way under its 52-week high of $83.45 and way higher than its 52-week low of $5.20.

Marathon’s Moving Average

Marathon’s worth is way higher than its 50-day moving average of $9.71 and way below its 200-day moving average of $25.18.

More news about Marathon.

4. Rock (RKT) – -10.94%

Rocket Companies, Inc. is a tech-driven mortgage, real estate, and ecommerce company in both the United States of America and Canada. The company operates in two distinct segments: Direct to Consumer (Partner Network) and Direct to Consumer (). Rocket Mortgage is a mortgage lender. Amrock provides title, property, settlement, and other services. Rocket Homes also offers home search platforms and referral networks for real estate agents. Rocket Auto provides virtual and centralized car sales support through online purchasing sites. Rocket Loans provides online personal loans. Core Digital Media is a digital display and social advertiser that specializes in mortgages, insurance and education; Rocket Solar connects homeowners to digital financing options through a team made up of qualified solar advisors; Truebill helps clients manage all aspects of their finances; Lendesk provides technology services that include a point-of-sale system for mortgage professionals, as well as a loan origination process for private lenders. Edison Financial also offers digital mortgage brokerage. The company also originates, closes and sells agency-conforming loans. Rocket Companies, Inc., was established in 1985. It is located in Detroit, Michigan. Rocket Companies, Inc. is a subsidiary Rock Holdings, Inc.

NYSE ended the session with Rock sliding 10.94% to $8.42 on Friday while NYSE dropped 0.02% to $15,338.15.

Volume

Today’s last reported volume for Rock is 3206680 which is 3.8% below its average volume of 3333510.

Rock’s last close was $9.45, 54.65% below its 52-week high of $20.84.

Rock’s Sales

Rock’s sales growth is a negative 38.6% for the current quarter and a decline by 41.5% for the next. The company’s growth estimates for the present quarter and the next is a negative 37% and a negative 50.9%, respectively.

Rock’s Revenue

Year-on-year quarterly revenue growth declined by 44.4%, now sitting on 13.18B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Rock’s stock is considered to be overbought (>=80).

Rock’s Stock Yearly Top and Bottom Value

Rock’s stock is valued at $8.42 at 17:35 EST, way under its 52-week high of $20.84 and way higher than its 52-week low of $6.27.

Rock’s Moving Average

Rock’s value is below its 50-day moving average of $8.47 and way below its 200-day moving average of $12.79.

More news about Rock.

5. Restoration Hardware Holdings (RH) – -10%

RH and its subsidiaries are retailers in home furniture. The company offers products from a variety of categories including lighting, furniture, textiles and bathware. It also sells decor, garden and outdoor items, as well as child and teenage furnishings. It sells its products via its retail galleries and Source Books. Source Books is a series catalog, which can also be accessed online at rh.com. It had a total of 38 RH Outlet stores and 67 RH Galleries in thirty states and District of Columbia, Canada. There were also 14 Waterworks showrooms in the United States. It was previously known as Restoration Hardware Holdings, Inc., but it changed its name in January 2017 to RH. RH was founded in Corte Madera in California in 2011.

NYSE ended the session with Restoration Hardware Holdings falling 10% to $265.18 on Friday, after two consecutive sessions in a row of gains. NYSE fell 0.02% to $15,338.15, after two sequential sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Restoration Hardware Holdings is 1006360 which is 25.44% above its average volume of 802254.

Restoration Hardware Holdings’s last close was $294.64, 60.43% under its 52-week high of $744.56.

The company’s growth estimates for the present quarter is 10% and a drop 18.8% for the next.

Restoration Hardware Holdings’s Revenue

Year-on-year quarterly revenue growth grew by 11.1%, now sitting on 3.76B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Restoration Hardware Holdings’s stock is considered to be overbought (>=80).

Restoration Hardware Holdings’s Stock Yearly Top and Bottom Value

Restoration Hardware Holdings’s stock is valued at $265.18 at 17:35 EST, way below its 52-week high of $744.56 and way above its 52-week low of $207.37.

Restoration Hardware Holdings’s Moving Average

Restoration Hardware Holdings’s value is under its 50-day moving average of $284.58 and way under its 200-day moving average of $451.54.

More news about Restoration Hardware Holdings.

6. 10x Genomics (TXG) – -9.76%

10x Genomics, Inc. is a life-science technology company that develops, sells consumables, software, and instruments for analysing biological systems across North America, Europe, Asia Pacific, Africa, China, Middle East, Africa, China, and China. It offers chromium, chromium connect, microfluidic chip, slides, reagents and other consumables. The company’s single-cell solutions run on its chromium instrument. These include single-cell gene expression to measure gene activity cell-by-cell; single-cell Assay for Transposase Accessible Chromati for measuring epigenetics including the physical organization and DNA sequence; and single-cell multiome ATAC+ gene expression to determine the epigenetic activity in multiple cells, tens or thousands at a time. Visium spatial gene Expression Solution is also offered by the company. This allows you to measure spatial patterns of gene expression across one tissue sample, or combine gene expression with protein co-detection. The company serves many institutions, including academic, government and biopharmaceutical. 10X Technologies, Inc. was the company’s previous name. In November 2014, it changed its name from 10X Genomics, Inc. 10x Genomics, Inc. is an American company that was founded in 2012. Its headquarters are in Pleasanton, California.

NASDAQ ended the session with 10x Genomics dropping 9.76% to $34.90 on Friday while NASDAQ fell 3.94% to $12,141.71.

Volume

Today’s last reported volume for 10x Genomics is 699967 which is 54.82% below its average volume of 1549380.

10x Genomics’s last close was $38.68, 79.76% under its 52-week high of $191.15.

The company’s growth estimates for the current quarter and the next is a negative 240% and a negative 26.7%, respectively.

10x Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 27.9%, now sitting on 490.49M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

10x Genomics’s stock is considered to be oversold (<=20).

10x Genomics’s Stock Yearly Top and Bottom Value

10x Genomics’s stock is valued at $34.90 at 17:35 EST, way below its 52-week high of $191.15 and higher than its 52-week low of $33.30.

10x Genomics’s Moving Average

10x Genomics’s worth is way under its 50-day moving average of $44.59 and way below its 200-day moving average of $93.32.

More news about 10x Genomics.

7. Bionano Genomics (BNGO) – -9.62%

Bionano Genomics, Inc. offers genome analysis software. Saphyr is a sample to result solution for structural variation analysis using optical genome mapping. It also offers Saphyr (a sample-to–result solution) for understanding genetic variation and functions. Saphyr Chip can be used as a consumable for packaging nanochannel arrays. Bionano Prep Kits, and DNA Labeling Kits, provide the necessary reagents, protocols, and procedures for extracting high molecular weight molecules. Saphyr, Bionano and NxClinical are also available. These servers allow for the analysis and interpretation genomic variants from both microarrays as well as next-generation sequencing data. It also offers laboratory and testing services, including FirstStepDx Plus, a chromosomal Microarray to determine an underlying cause of autism spectrum disorder and developmental delay in people with intellectual disabilities; Fragile X (FXS), testing services; NextStepDx plus, an exome sequencing test that identifies genetic variants associated with childhood disorders; EpiPanelDx P, a panel for genetic testing for children who have suffered seizures, infantile spasms or encephalopathy; and PGx, which identifies more than 60 genes. It was established in 2003 in San Diego.

NASDAQ ended the session with Bionano Genomics dropping 9.62% to $2.59 on Friday while NASDAQ slid 3.94% to $12,141.71.

Volume

Today’s last reported volume for Bionano Genomics is 6722380 which is 20.08% below its average volume of 8411800.

Bionano Genomics’s last close was $2.86, 55.1% below its 52-week high of $6.37.

Bionano Genomics’s Sales

Bionano Genomics’s sales growth is 62.9% for the ongoing quarter and 59.8% for the next. The company’s growth estimates for the present quarter and the next is a negative 28.6% and a negative 28.6%, respectively.

Bionano Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 57.9%, now sitting on 17.98M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Bionano Genomics’s stock is considered to be oversold (<=20).

Bionano Genomics’s Stock Yearly Top and Bottom Value

Bionano Genomics’s stock is valued at $2.59 at 17:35 EST, way under its 52-week high of $6.37 and way higher than its 52-week low of $1.16.

Bionano Genomics’s Moving Average

Bionano Genomics’s value is way higher than its 50-day moving average of $1.56 and below its 200-day moving average of $2.70.

More news about Bionano Genomics.

8. Arcturus Therapeutics (ARCT) – -9.47%

Arcturus Therapeutics Holdings Inc. is an RNA medicines firm that focuses on vaccine development for rare infections, liver diseases, and other respiratory illnesses in the United States. LUNAR -OTC is the company’s program to develop ornithine transcarbamylase deficiency (OTC); and LUNAR -CF for cystic fibrosis lung diseases caused by mutations of cystic fibrosis Transmembrane Conductance Regulator (CFTR). Other vaccine programs include LUNAR -COV19, and LUNAR – FLU. Vinbiocare Biotechnology Joint Stock Company manufactures COVID-19 vaccines. Janssen Pharmaceuticals, Inc. develops nucleic-acid-based therapeutic candidates to treat hepatitis B viruses. Ultragenyx Pharmaceutical, Inc. develops mRNA therapeutic candidate candidates to treat rare diseases. CureVac AG develops mRNA vaccine and therapeutic candidates to various indications. The LUNAR-COV19 vaccine will be developed by the Singapore Economic Development Board, Duke-NUS Medical School, and Millennium Pharmaceuticals, Inc. It was established in San Diego in 2013.

NASDAQ ended the session with Arcturus Therapeutics falling 9.47% to $15.01 on Friday while NASDAQ fell 3.94% to $12,141.71.

Volume

Today’s last reported volume for Arcturus Therapeutics is 193117 which is 67.47% below its average volume of 593812.

Arcturus Therapeutics’s last close was $16.58, 74.49% under its 52-week high of $65.00.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is 51.9% for the current quarter and a decline by 42.1% for the next. The company’s growth estimates for the present quarter and the next is 15.5% and 22.4%, respectively.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 158.9%, now sitting on 12.36M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be oversold (<=20).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $15.01 at 17:35 EST, way under its 52-week high of $65.00 and way higher than its 52-week low of $11.70.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s worth is way under its 50-day moving average of $17.03 and way below its 200-day moving average of $27.09.

More news about Arcturus Therapeutics.

9. 3M Company (MMM) – -9.24%

3M Company is a global technology company that offers a variety of services. The company operates in four areas: Safety and Industrial, Transportation and Electronics, Health Care and Consumer. The Safety and Industrial section offers industrial abrasives and metalworking solutions, as well as closures systems for personal hygiene, masking and packaging, and products and materials that are used in construction and maintenance. It also provides electrical products and materials to support electrical original equipment manufacturer, power distribution and manufactures, and structural adhesives and tapes. Transportation and Electronics offers ceramic solutions, attachment tapes and films, sound and temperature management for transport vehicles, premium large format graphics films for advertising and fleet signs, light management films and electronic assembly solutions, packaging and interconnection options, and reflective signage to ensure highway safety and vehicle safety. Healthcare offers solutions for food safety, health procedure coding, reimbursement software, skin, wound care and infected prevention products and services, as well as dental and orthodontic solutions. Consumer products include consumer products such as consumer braces, support, and consumer respirators, cleaning products for home, retail abrasives and paint accessories, DIY car care products, picture hanging and consumer air quality products. The company sells its products via e-commerce, traditional wholesalers and retailers as well as jobbers and distributors. It was established in St. Paul in Minnesota in 1902.

NYSE ended the session with 3M Company falling 9.24% to $129.57 on Friday while NYSE slid 0.02% to $15,338.15.

Volume

Today’s last reported volume for 3M Company is 34435000 which is 644.23% above its average volume of 4626900.

3M Company’s last close was $142.76, 31.68% below its 52-week high of $208.95.

The company’s growth estimates for the present quarter is 0.4% and a drop 3.8% for the next.

3M Company’s Revenue

Year-on-year quarterly revenue growth grew by 24.7%, now sitting on 34.73B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

3M Company’s stock is considered to be overbought (>=80).

3M Company’s Stock Yearly Top and Bottom Value

3M Company’s stock is valued at $129.57 at 17:36 EST, way under its 52-week low of $163.38.

3M Company’s Moving Average

3M Company’s value is way below its 50-day moving average of $178.88 and way under its 200-day moving average of $191.06.

More news about 3M Company.

10. NVIDIA (NVDA) – -9.11%

NVIDIA Corporation offers graphics, compute, networking and other solutions throughout the United States and abroad. GeForce GPUs are available for PCs and gaming, as well as the GeForce Now game streaming service. The Graphics segment also offers Quadro/NVIDIA RX GPUs to run enterprise graphics, vGPU software, which can be used for virtual and cloud-based computing, automotive infotainment platforms, and Omniverse software that allows for 3D design and creation of virtual worlds. The Compute & Networking section provides Data Center platforms for AI, HPC and accelerated computing, Mellanox networking solutions, automotive AI Cockpit and autonomous driving development agreements and solutions, as well as Mellanox interconnect solutions, Mellanox network and interconnect solutions, Mellanox software for building 3D designs and virtual worlds, Omniverse software for creating 3D models and textures, and NVIDIA AI Enterprise. Products are sold to the automotive, professional visualization and gaming markets. NVIDIA Corporation sells its products to original equipment manufacturers, original device manufacturers, system builders, add-in board manufacturers, retailers/distributors, independent software vendors, Internet and cloud service providers, automotive manufacturers and tier-1 automotive suppliers, mapping companies, start-ups, and other ecosystem participants. NVIDIA Corporation has a strategic partnership with Kroger Co. NVIDIA Corporation is located in Santa Clara (California) and was founded in 1993.

NASDAQ ended the session with NVIDIA dropping 9.11% to $162.81 on Friday, after three successive sessions in a row of gains. NASDAQ slid 3.94% to $12,141.71, after two successive sessions in a row of gains, on what was a very bearish trend trading session today.

Volume

Today’s last reported volume for NVIDIA is 71319100 which is 37.23% above its average volume of 51967300.

NVIDIA’s last close was $179.13, 48.3% below its 52-week high of $346.47.

The company’s growth estimates for the present quarter and the next is 20.2% and 12.8%, respectively.

NVIDIA’s Revenue

Year-on-year quarterly revenue growth grew by 46.4%, now sitting on 29.54B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

NVIDIA’s stock is considered to be oversold (<=20).

NVIDIA’s Stock Yearly Top and Bottom Value

NVIDIA’s stock is valued at $162.81 at 17:36 EST, way below its 52-week high of $346.47 and way above its 52-week low of $140.55.

NVIDIA’s Moving Average

NVIDIA’s value is under its 50-day moving average of $169.50 and way under its 200-day moving average of $228.63.

More news about NVIDIA.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here